Advertisement

Medical Microbiology and Immunology

, Volume 201, Issue 1, pp 113–116 | Cite as

High detection rate of Trichomonas vaginalis in benign hyperplastic prostatic tissue

  • Dieter MittereggerEmail author
  • Stephan W. Aberle
  • Athanasios Makristathis
  • Julia Walochnik
  • Wolfgang Brozek
  • Michael Marberger
  • Gero Kramer
Rapid Communication

Abstract

While Trichomonas vaginalis, a protozoan parasite, is a well-investigated pathogen in the female population, there is little awareness of its significance in the male uro-genital tract. The presence of T. vaginalis in the prostate gland has only been scarcely investigated and has never been attested in conditions other than clinical prostatitis. Still, by some authors, this organ is regarded as ecologic niche for T. vaginalis. Since normal prostate tissue of sufficient quality is hard to come by, we investigated samples from 86 patients (mean age 68.7 ± 7.6 years) suffering from benign prostatic hyperplasia (BPH), a medical condition currently ranked as noninfectious, but characterized by chronic inflammatory tissue infiltrates of unknown etiology. Applying two different PCR protocols and sequence analysis of the respective amplicons, we detected T. vaginalis DNA in 29/86 (34%) BPH tissue samples, whereas in only 2/86 (2.3%) cases T. vaginalis grew in culture. Detection of T. vaginalis DNA correlated significantly (P < 0.01) with elevated peripheral blood monocytic cell counts, appearing along with protozoan infections. Given the unexpected high prevalence of T. vaginalis in BPH tissue of a nonselected, elderly study population from Austria, further epidemiological studies have to confirm this finding. Potential interactions of T. vaginalis in its prostatic habitat may be investigated with respect to their possible contribution to the inflammatory pathogenesis of BPH, since inflammatory cytokines have been shown to sustain prostatic hyperplastic growth.

Keywords

Trichomonas vaginalis Benign prostatic hyperplasia Prostate gland Chronic inflammation Infection 

Notes

Acknowledgments

The authors thank Iveta Häfeli and Jacek Pietrzak for excellent technical assistance and are grateful to Prof. Herbert Auer (Division of Medical Parasitology, Department of Specific Prophylaxis and Tropical Medicine) for inspiring discussion, and to Prof. Alexander Hirschl (Division of Clinical Microbiology, Department of Laboratory Medicine) and Prof. Elisabeth Nagy (Institute of Clinical Microbiology, University of Szeged, HU) for careful revision of the manuscript. We are indebted to the Division of Clinical Microbiology, Department of Laboratory Medicine, Medical University Vienna, Austria for providing the opportunity to finalize the present study.

Ethical standards

All investigations in the present study comply with Austrian law.

Conflict of interest

The authors declare that they have no conflicts of interest.

References

  1. 1.
    Petrin D, Delgaty K, Bhatt R, Garber G (1998) Clinical and microbiological aspects of Trichomonas vaginalis. Clin Microbiol Rev 11(2):300–317PubMedGoogle Scholar
  2. 2.
    Schwebke JR, Burgess D (2004) Trichomoniasis. Clin Microbiol Rev 17(4):794–803 table of contentsPubMedCrossRefGoogle Scholar
  3. 3.
    Walochnik J, Aspock H (2002) Trichomonas vaginalis—a parasitic pathogen being causative of a veneral disease (German). Denisia 6, cataloges of the Federal State Museum of Upper Austria 184:145–161Google Scholar
  4. 4.
    Gaydos CA, Maldeis N, Hardick A, Hardick J, Quinn TC (2009) Mycoplasma genitalium compared to Chlamydia, Gonorrhea, and Trichomonas as an etiologic agent of urethritis in men attending STD clinics. Sex Transm Infect 85(6):438–440Google Scholar
  5. 5.
    Schwebke JR, Hook 3rd EW (2003) High rates of Trichomonas vaginalis among men attending a sexually transmitted diseases clinic: implications for screening and urethritis management. J Infect Dis 188(3):465–468PubMedCrossRefGoogle Scholar
  6. 6.
    Skerk V, Schonwald S, Krhen I, Markovinovic L, Beus A, Kuzmanovic NS, Kruzic V, Vince A (2002) Aetiology of chronic prostatitis. Int J Antimicrob Agents 19(6):471–474PubMedCrossRefGoogle Scholar
  7. 7.
    Krieger JN, Riley DE, Roberts MC, Berger RE (1996) Prokaryotic DNA sequences in patients with chronic idiopathic prostatitis. J Clin Microbiol 34(12):3120–3128PubMedGoogle Scholar
  8. 8.
    Lee JC, Muller CH, Rothman I, Agnew KJ, Eschenbach D, Ciol MA, Turner JA, Berger RE (2003) Prostate biopsy culture findings of men with chronic pelvic pain syndrome do not differ from those of healthy controls. J Urol 169(2):584–587 discussion 587–588PubMedCrossRefGoogle Scholar
  9. 9.
    Sfanos KS, Sauvageot J, Fedor HL, Dick JD, De Marzo AM, Isaacs WB (2008) A molecular analysis of prokaryotic and viral DNA sequences in prostate tissue from patients with prostate cancer indicates the presence of multiple and diverse microorganisms. Prostate 68(3):306–320PubMedCrossRefGoogle Scholar
  10. 10.
    Emberton M, Andriole GL, de la Rosette J, Djavan B, Hoefner K, Vela Navarrete R, Nordling J, Roehrborn C, Schulman C, Teillac P, Tubaro A, Nickel JC (2003) Benign prostatic hyperplasia: a progressive disease of aging men. Urology 61(2):267PubMedCrossRefGoogle Scholar
  11. 11.
    Fitzpatrick JM (2006) The natural history of benign prostatic hyperplasia. BJU Int 97(Suppl 2):3–6 (discussion 21–22)PubMedCrossRefGoogle Scholar
  12. 12.
    Kramer G, Steiner GE, Handisurya A, Stix U, Haitel A, Knerer B, Gessl A, Lee C, Marberger M (2002) Increased expression of lymphocyte-derived cytokines in benign hyperplastic prostate tissue, identification of the producing cell types, and effect of differentially expressed cytokines on stromal cell proliferation. Prostate 52(1):43–58PubMedCrossRefGoogle Scholar
  13. 13.
    Steiner GE, Stix U, Handisurya A, Willheim M, Haitel A, Reithmayr F, Paikl D, Ecker RC, Hrachowitz K, Kramer G, Lee C, Marberger M (2003) Cytokine expression pattern in benign prostatic hyperplasia infiltrating T cells and impact of lymphocytic infiltration on cytokine mRNA profile in prostatic tissue. Lab Invest 83(8):1131–1146PubMedCrossRefGoogle Scholar
  14. 14.
    Roehrborn C, Kaplan S, Noble W, Lucia S, Slawin K, McVary K, Kusek J, Nyberg L Jr (2005) The impact of acute or chronic inflammation in baseline biopsy on the risk of clinical progression of BPH: results from the MTOPS study. J Urol 173(Suppl 4):346 (Abstr.)Google Scholar
  15. 15.
    Mishra VC, Allen DJ, Nicolaou C, Sharif H, Hudd C, Karim OM, Motiwala HG, Laniado ME (2007) Does intraprostatic inflammation have a role in the pathogenesis and progression of benign prostatic hyperplasia? BJU Int 100(2):327–331PubMedCrossRefGoogle Scholar
  16. 16.
    Lucia MS, Lambert JR (2008) Growth factors in benign prostatic hyperplasia: basic science implications. Curr Urol Rep 9(4):272–278PubMedCrossRefGoogle Scholar
  17. 17.
    Kramer G, Mitteregger D, Marberger M (2007) Is benign prostatic hyperplasia (BPH) an immune inflammatory disease? Eur Urol 51(5):1202–1216PubMedCrossRefGoogle Scholar
  18. 18.
    Diamond LS, Harlow DR, Cunnick CC (1978) A new medium for the axenic cultivation of Entamoeba histolytica and other Entamoeba. Trans R Soc Trop Med Hyg 72(4):431–432PubMedCrossRefGoogle Scholar
  19. 19.
    Madico G, Quinn TC, Rompalo A, McKee KT Jr, Gaydos CA (1998) Diagnosis of Trichomonas vaginalis infection by PCR using vaginal swab samples. J Clin Microbiol 36(11):3205–3210PubMedGoogle Scholar
  20. 20.
    Kengne P, Veas F, Vidal N, Rey JL, Cuny G (1994) Trichomonas vaginalis: repeated DNA target for highly sensitive and specific polymerase chain reaction diagnosis. Cell Mol Biol (Noisy-le-grand) 40(6):819–831PubMedGoogle Scholar
  21. 21.
    Crucitti T, Van Dyck E, Tehe A, Abdellati S, Vuylsteke B, Buve A, Laga M (2003) Comparison of culture and different PCR assays for detection of Trichomonas vaginalis in self collected vaginal swab specimens. Sex Transm Infect 79(5):393–398PubMedCrossRefGoogle Scholar
  22. 22.
    Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ (1990) Basic local alignment search tool. J Mol Biol 215(3):403–410. doi: 10.1006/jmbi.1990.9999 PubMedGoogle Scholar
  23. 23.
    Cornbleet P, Astarita R, Wolf P (1991) White blood cell and platelet disorders. In: Howanitz J, Howanitz P (eds) Laboratory medicine, 1st edn. Churchill Livingstone, New York, Edinburgh, London, Melburne, Tokyo, p 554Google Scholar
  24. 24.
    Fichorova RN, Trifonova RT, Gilbert RO, Costello CE, Hayes GR, Lucas JJ, Singh BN (2006) Trichomonas vaginalis lipophosphoglycan triggers a selective upregulation of cytokines by human female reproductive tract epithelial cells. Infect Immun 74(10):5773–5779PubMedCrossRefGoogle Scholar
  25. 25.
    Castro P, Xia C, Gomez L, Lamb DJ, Ittmann M (2004) Interleukin-8 expression is increased in senescent prostatic epithelial cells and promotes the development of benign prostatic hyperplasia. Prostate 60(2):153–159PubMedCrossRefGoogle Scholar
  26. 26.
    Giri D, Ittmann M (2001) Interleukin-8 is a paracrine inducer of fibroblast growth factor 2, a stromal and epithelial growth factor in benign prostatic hyperplasia. Am J Pathol 159(1):139–147PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2011

Authors and Affiliations

  • Dieter Mitteregger
    • 1
    • 2
    Email author
  • Stephan W. Aberle
    • 3
  • Athanasios Makristathis
    • 2
  • Julia Walochnik
    • 4
  • Wolfgang Brozek
    • 1
  • Michael Marberger
    • 1
  • Gero Kramer
    • 1
  1. 1.Ludwig Boltzmann Cluster of Urology, Department of UrologyMedical University ViennaViennaAustria
  2. 2.Division of Clinical Microbiology, Department of Laboratory MedicineMedical University ViennaViennaAustria
  3. 3.Department for VirologyMedical University ViennaViennaAustria
  4. 4.Medical Parasitology, Institute of Specific Prophylaxis and Tropical Medicine, Department of Pathophysiology, Infectiology and ImmunologyMedical University ViennaViennaAustria

Personalised recommendations